Alexion’s Bleeding Antidote to Be Approved as Early as This Month

Japan’s health ministry plans to approve Alexion Pharmaceuticals’ andexanet alfa, an antidote for factor Xa inhibitors, now that it has cleared issues around its data integrity, an official said on March 23. The approval is expected as early as this...read more